Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone
/in Colorectal Cancer, Hyperthermia, International PublicationsPhase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsTwo avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro
/in International Publications, Newcastle Disease Virus, Pancreatic CancerAutologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
/in Breast Cancer, Dendritic Cells, International PublicationsNK cells: key to success of DC-based cancer vaccines?
/in Dendritic Cells, International PublicationsThe use of oncolytic viruses to overcome lung cancer drug resistance
/in International Publications, Newcastle Disease VirusMorphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients
/in Dendritic Cells, International Publications, Thyroid CancerDendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer
/in Dendritic Cells, International Publications, Urothelial Carcinoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer